Truvestments Capital LLC Neuro Bo Pharmaceuticals, Inc. Transaction History

Truvestments Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.4 - $0.9 $11 - $26	29 New	29 $0
Q1 2022 May 02, 2022	SELL	$0.72 - $1.54 $20 - $44	-29 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$3.93 - $6.68 $314 - $534	-80 Reduced 73.39%	29 $0
Q4 2020 Feb 17, 2021	BUY	$5.02 - $6.59 $547 - $718	109 New	109 $0
Q3 2020 Nov 13, 2020	SELL	$5.41 - $8.67 $589 - $945	-109 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$8.05 - $29.44 $877 - $3,208	109 New	109 $0

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.